Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 13.3% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZY
2876
DELISTED
Zymergen Inc. Common Stock
ZY
| $2.38M | ﹤0.01% |
+59,451
| New | +$2.35M |
|
2877
Arcutis Biotherapeutics
ARQT
$3.29B
| $2.38M | ﹤0.01% |
87,079
+178
| +0.2% | +$5.01K |
|
2878
Aclaris Therapeutics
ACRS
$851M
| $2.38M | ﹤0.01% |
135,242
+24,086
| +22% | +$547K |
|
|
NBP
2879
NovaBridge Biosciences American Depositary Shares
NBP
$227M
| $2.38M | ﹤0.01% |
+28,290
| New | +$1.87M |
|
2880
iShares MSCI Thailand ETF
THD
$353M
| $2.38M | ﹤0.01% |
30,459
-7,463
| -20% | -$599K |
|
|
MMP
2881
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $2.37M | ﹤0.01% |
48,480
+2,009
| +4% | +$97.4K |
|
2882
Verastem
VSTM
$596M
| $2.37M | ﹤0.01% |
48,507
-4,311
| -8% | -$180K |
|
2883
Anterix
ATEX
$1.79B
| $2.37M | ﹤0.01% |
39,433
+2,678
| +7% | +$134K |
|
2884
IES Holdings
IESC
$15.1B
| $2.36M | ﹤0.01% |
45,921
-2,587
| -5% | -$134K |
|
|
AMNB
2885
DELISTED
American National Bankshares Inc
AMNB
| $2.35M | ﹤0.01% |
75,750
+1,172
| +2% | +$39.5K |
|
2886
PubMatic
PUBM
$801M
| $2.35M | ﹤0.01% |
+60,105
| New | +$2.5M |
|
|
HGEN
2887
DELISTED
HUMANIGEN, INC.
HGEN
| $2.35M | ﹤0.01% |
134,886
+113,092
| +519% | +$2.06M |
|
|
NAPA
2888
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $2.34M | ﹤0.01% |
+106,171
| New | +$2.07M |
|
|
CTO
2889
CTO Realty Growth
CTO
$825M
| $2.34M | ﹤0.01% |
131,208
+5,517
| +4% | +$97.7K |
|
2890
Capital City Bank Group
CCBG
$898M
| $2.33M | ﹤0.01% |
90,507
-4,422
| -5% | -$115K |
|
|
RNAM
2891
DELISTED
Avidity Biosciences
RNAM
| $2.33M | ﹤0.01% |
94,416
+9,965
| +12% | +$232K |
|
|
ACRE
2892
Ares Commercial Real Estate
ACRE
$262M
| $2.32M | ﹤0.01% |
157,831
+1,853
| +1% | +$27.8K |
|
2893
MVB Financial
MVBF
$398M
| $2.3M | ﹤0.01% |
53,826
+1,132
| +2% | +$46.2K |
|
2894
BrightView Holdings
BV
$1.09B
| $2.3M | ﹤0.01% |
142,466
-3,676
| -3% | -$64.5K |
|
|
EPZM
2895
DELISTED
Epizyme, Inc
EPZM
| $2.29M | ﹤0.01% |
275,757
-69,655
| -20% | -$587K |
|
2896
PAVmed
PAVM
$37.2M
| $2.29M | ﹤0.01% |
795
+431
| +118% | +$1.02M |
|
2897
Instil Bio
TIL
$50.1M
| $2.29M | ﹤0.01% |
5,919
+4,585
| +344% | +$1.7M |
|
2898
WisdomTree Europe SmallCap Dividend Fund
DFE
$170M
| $2.28M | ﹤0.01% |
31,041
+5,779
| +23% | +$431K |
|
2899
United States Lime & Minerals
USLM
$3.37B
| $2.28M | ﹤0.01% |
81,835
+820
| +1% | +$23.1K |
|
2900
Utah Medical Products
UTMD
$226M
| $2.27M | ﹤0.01% |
26,733
+1,168
| +5% | +$101K |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.